Taiwanese dBio set to open its European HQ and AI research center in Luxembourg to scale its next-gen health wearables.
The future of human performance may be taking shape in Luxembourg. Decentralized Biotechnology Intelligence (dBio), a Taiwanese healthtech innovator, announced the set up of its European headquarters and a new AI research center in Luxembourg. The move marks a pivotal moment in the company’s international expansion, with Luxembourg serving as the gateway for dBio’s growth across the continent.
The new site will function as a key R&D hub for dBio’s GMOT Cloud platform, an advanced wearable system that integrates AI-driven motion tracking, real-time health data, and digital coaching. At a press event held in Luxembourg City, the company showcased the platform through a live demonstration and premiere of its official launch video.
“Today, there are a tremendous amount of products: Fitbit, Apple Watch, Oura Ring. They give you indications, but what they don’t give you is precise, accurate data,” said Hubertus Hoyt, former Nike VP, and dBio’s newest Board Advisor. “Our mission of this company is to take technology, bring it into everybody’s life in a very accurate and precise way and then transfer that to health and well-being.”
Precise insights thanks to cutting-edge sensors
At the center of dBio’s innovation is a shoe insole. With sensors capable of measuring forward, lateral, and vertical motion, pressure, and gait asymmetry, it provides granular feedback for a wide array of users, from professional athletes to rehabilitating patients. The GMOT Cloud platform processes this data in real time, delivering AI-generated coaching cues and long-term health insights.
In parallel, dBio’s wearable device Steth Cloud tracks EKG-like biometrics around the clock, merging sports science with clinical-grade possibilities. The firm says its aim is to bridge the gap between lifestyle health tracking and medically relevant data.
The company has filed more than 75 patents, with global validation — including from Japan’s stringent tech standards. Everything, from hardware to algorithms, is developed in-house, maintaining control over intellectual property and data integrity. The company currently employs around 25 people in Taiwan.
“Luxembourg is one of the best-connected countries in Europe.”
Mario Grotz, CEO of Luxinnovation
Healthtech part of Luxembourg’s official AI strategy
Luxembourg’s strategic position, robust data infrastructure, and investment in AI and digitalization were decisive factors for dBio’s expansion. “Luxembourg is one of the best-connected countries in Europe,” said Mario Grotz, CEO of Luxinnovation, who pledged continued support to accelerate dBio’s R&D and market integration efforts.
Grotz, highlighting dBio first collaboration with Lunex University, confirmed that the government-backed agency will support dBio through access to grants, R&D networks, and guidance within Luxembourg’s burgeoning digital health landscape. Grotz also announced that the health sector will be part of Luxembourg’s official AI strategy for the coming years. For a country rapidly cementing its position as a European tech testbed, Luxembourg just gained another player with global potential.
